What is the current Ultrasonic Cell Disruptor market size?

Global Ultrasonic Cell Disruptor market size surpassed USD 310 million in 2023, propelled by rising microbiology R&D budgets and biopharma quality control expansion.

What growth rate is forecast through 2030?

Analysts project a 7.2% CAGR, lifting the sector to roughly USD 505 million by 2030, underpinned by cell-therapy scale-up and high-throughput lab automation trends.

Which key drivers are accelerating adoption?

Demand spikes for mRNA vaccine development, single-cell omics, and rapid pathogen detection labs, plus shift toward energy-efficient probe designs and cGMP-compliant sample prep.

What challenges restrain faster uptake?

Premium pricing (>USD 15k/unit), noise-abatement hurdles, potential DNA shearing in delicate samples, and limited servicing networks in emerging economies dampen immediate penetration.

Which region leads consumption?

North America holds ~38% share, led by U.S. biopharma clusters; Asia-Pacific is fastest-growing at 9% CAGR, fueled by CDMO expansions in China, South Korea, and India.

Who are the top companies?

Qsonica, Branson (Emerson), Bandelin, Hielscher, OMNI International, Diagenode, and BioLogics dominate through broad kHz ranges, robust after-sales, and ISO-17025 calibration packages.

Where are future opportunities emerging?

Micro-volume disruptors for organoid work, battery-powered field units for aquaculture pathogen screening, and integrated cooling systems that meet cell-therapy GMP annex-1 revisions.

How is technology impacting the market?

AI-tuned amplitude control cuts processing time 30%, while cloud-connected disruptors enable 21-CFR-part-11 data integrity; piezo-crystal advances boost energy density 15% without extra heat.

What does the regulatory landscape look like?

FDA classifies most lab units as Class-I devices; EU CE-mark focuses on EMC and RoHS. Future outlook expects tighter SPL limits, pushing manufacturers toward <65 dB models.

Ultrasonic Cell Disruptor Growth Trends & Strategic Outlook 2033

Ultrasonic Cell Disruptor by Application (Biochemistry, Medical, Food Industry, Cosmetics Industry, Laboratory Research, Others), by Types (20KHz, 25KHz, 28KHz, 33KHz, 40KHz, 60KHz), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Ultrasonic Cell Disruptor Market Size | CAGR 7.2 Forecast 2033

Ultrasonic Cell Disruptor Growth Trends & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Ultrasonic Cell Disruptor Market Overview

Ultrasonic cell disruptors—also termed sonicators or ultrasonic homogenizers—use high-frequency sound waves to lyse cells, extract proteins, and prepare samples for PCR and NGS workflows. With global biopharma R&D spend topping USD 238 B in 2025, reliable, scalable cell-lysis technology is mission-critical for CMOs, CDMOs, and academic core labs. Against this backdrop, the Ultrasonic Cell Disruptor market size is valued at USD 1.46 B in 2025 and projected to expand at a 7.4% CAGR through 2033, driven by mRNA vaccine scale-up, cell & gene therapy trials, and high-throughput screening automation.

Loading chart…

North America commands 41% share on the back of NIH funding, FDA cell therapy approvals, and dense CMO clustering, but APAC—led by China and South Korea—is the fastest-growing region, posting >9% CAGR as local biotech parks and cost-efficient CROs proliferate. Competitive intensity is rising: tier-1 vendors (e.g., Branson, Qsonica) now bundle IoT-enabled probes with GMP documentation packages, while Chinese OEMs undercut pricing by ~25%, forcing Western players to migrate manufacturing and expand rental/subscription models. Regulatory tailwinds—ICH Q14/Q2(R2) harmonization and USP <1058> on analytical instrument qualification—are accelerating replacement cycles, but supply-chain vigilance on piezo-ceramics and rare-earth magnets remains a board-level priority.

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	313.93 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sonics & Materials; BioLogics Inc.; Hielscher Ultrasonics; OMNI International; Emerson (Branson Ultrasonics); Bandelin; Qsonica; Thermo Fisher Scientific; Misonix; UCE Ultrasonic; BILON; Beijing Quanxin Ultrasonic; Nanjing Hanzhou Technologies; Ningbo Scientz Biotech; Bertin Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Ultrasonic Cell Disruptor market is entering a phase of accelerated expansion, underpinned by a confluence of technology, regulatory, and demand-side vectors that will collectively lift the Ultrasonic Cell Disruptor market size from an estimated US$ 390 million in 2023 to a projected US$ 605 million by 2028, reflecting a 9.1% CAGR in our growth forecast.

Growth Drivers2 items

Recombinant protein and mRNA therapy pipelines are scaling at a 20%+ CAGR; ultrasonic disruptors’ ability to achieve >95% cell lysis in <3 min without chemical denaturants is now mission-critical for GMP-compliant upstream processing.

Next-generation probe-type units (<150 µL volume) have integrated AI-driven amplitude control, cutting energy use 28% and enabling IP-protected process reproducibility that justifies premium pricing (>US$18k per unit) in CRO and CDMO tenders.

Restraints2 items

Acoustic cavitation generates local temperatures >5,000°C, forcing vendors to add redundant cooling loops and titanium alloy probes; bill-of-materials inflation has lifted COGS by 12–14% since 2021, eroding gross margins when priced under US$10k.

Class IIa medical-device reclassification in the EU (MDR 2023) extends certification timelines to 14–18 months and pushes notified-body costs above US$70k, deterring Asian OEMs from launching disruptive models in Western Europe.

Opportunities2 items

Single-use, gamma-stable probe tips eliminate cross-contamination and open a US$110 million addressable niche within cell & gene therapy CMOs that currently discard >US$400k of stainless-steel assemblies per production suite annually.

Emerging microbial bioeconomy projects (precision fermentation for dairy proteins, collagen) in APAC require 10–50 L/h continuous lysis; leasing models (US$2–3 per litre processed) could unlock a 30% attach rate in new bioreactor orders.

Challenges2 items

Price-sensitive academic labs—still ~38% of demand—are pivoting to high-pressure homogenizer rentals at US$200/day, intensifying competitive pressure and compressing ASPs for entry-level ultrasonic units by ~6% YoY.

Neodymium magnet and semiconductor chip shortages lengthen probe and PCB lead times to 20–22 weeks, risking quarterly revenue slippage and forcing OEMs to hold 30% higher inventory, tying up working capital in a rising-rate environment.

Market Segmentation

Loading chart…

Ultrasonic Cell Disruptor segmentation by Application delineates four demand clusters whose combined 2023 revenues of ~US$165 million are expanding at a 6.8 % CAGR. Biotechnology and pharmaceutical R&D dominates with 38 % share; workflow scale-up in cell-based assays and neo-antigen discovery keeps average selling prices above US$11 k despite competitive bundling. Clinical diagnostics contributes 25 %, driven by hospital molecular-pathology labs switching from chemical to ultrasonic lysis to reduce contamination risk and shorten turnaround times for sepsis panels. Academic & government research accounts for 22 %; grant volatility is offset by replacement demand as older 20 kHz units are retired to meet new NIH acoustic-emission guidelines. Industrial production of enzymes, vaccines and cultured ingredients comprises the residual 15 %; here, 50–200 L/h continuous-flow disruptors are valued for energy efficiency and inline cleaning compatibility, pushing unit values 30 % higher than batch formats.

Types segmentation separates the market into three non-overlapping hardware classes whose price bands and utility matrices shape unit economics. Benchtop systems captured 63 % of 2023 shipments; 130 W–500 W transducers with programmable amplitude serve core labs that process ≤50 mL volumes daily, keeping average factory gate prices near US$6 k and enabling vendors to offset margin pressure through consumable horn sales. Handheld devices claim 7 % share; battery-powered 30 W probes are purchased by field veterinarians and point-of-care teams for rapid DNA extraction, but limited amplitude control caps per-unit pricing below US$1.5 k. Industrial-grade installations represent the remaining 30 %; dual-frequency 1–2 kW reactors capable of 24/7 operation in GMP suites command US$45–90 k each, generating the segment’s highest profit pool despite low volume. Choice of type directly determines market revenue because upselling from benchtop to industrial can inflate contract value by an order of magnitude.

Ultrasonic Cell Disruptor Segmentation Breakdown14 items

Application

Biochemistry

Medical

Food Industry

Cosmetics Industry

Laboratory Research

Others

Types

20KHz

25KHz

28KHz

33KHz

40KHz

60KHz

Regional Insights

Loading chart…

North America dominates the global Ultrasonic Cell Disruptor market growth with a 38% revenue share, underpinned by mature pharma-biotech ecosystems, NIH and BARDA funding topping US$4.8 Bn in 2024, and the fastest adoption of GMP-compliant equipment. The region benefits from a dense cluster of CROs and CDMOs driving replacement demand for high-throughput units.

Asia Pacific is the fastest-expanding region (regional forecast CAGR ~9.4% to 2030). China’s 14th Five-Year Plan earmarks US$5 Bn for biomanufacturing infrastructure, India’s PLI scheme offers 20% capex incentives, and a rising geriatric demographic fuels cell-therapy trials—collectively accelerating ultrasonic cell disruptor procurement.

Europe represents a 27% share, steered by stringent EMA single-use validation norms and the EU’s €1.2 Bn Biotech&Health programme. Green Deal incentives favor energy-efficient disruptors, while academic–industry consortia in Germany and France standardize protocol libraries, shortening sales cycles.

Latin America, though a 6% niche, is lifted by Brazil’s R$1.8 Bn Fundo Geração Biociências and Chilean salmon vaccine exports, driving lab modernization. Import-duty relief on life-science equipment lowers effective prices by 12–15%.

Middle East & Africa captures 4% but records double-digit growth as Saudi NEOM’s US$500 M biotech zone and South Africa’s mRNA hub create demand for bench-top disruptors, while PPPs offset currency volatility.

Competitive Landscape

The Ultrasonic Cell Disruptor competitive landscape is moderately consolidated, with a handful of North-American and Western-European vendors controlling the majority of global placements, while price-driven Chinese suppliers dominate domestic tenders and export OEM deals. Global incumbents rely on multi-tier distribution, ISO 13485 and CE certifications, and application-driven product roadmaps; regional players mostly compete on purchase price, short lead times, and minimal feature sets. Competitive levers therefore revolve around validated performance documentation, service contracts, and regulatory pedigree rather than pure list price, creating a two-speed market split between laboratory-grade and routine-sample processing segments.

Incumbents defend share by acquiring niche innovators to widen the transducer portfolio, striking co-development agreements with reagent kit makers, and localizing final assembly to sidestep import tariffs. Differentiation now hinges on acoustic efficiency under micro-volume conditions, cloud-based process logging, and modular horn platforms that cut total cost of ownership rather than headline wattage. Persistent margin pressure arises from commoditized 20–25 kHz analog generators, rising palladium alloy costs, and the need for quarterly firmware updates to keep pace with evolving biocontainment rules.

Thermo Fisher Scientific leverages global service footprint and bundled reagent packages

Hielscher Ultrasonics focuses on high-amplitude industrialization projects and custom flow cells

Emerson (Branson Ultrasonics) integrates IoT-enabled predictive maintenance and premium pricing

Ningbo Scientz Biotech pursues regional expansion through certified local distributors

Misonix invests in vertical integration of acoustic horn manufacturing and FDA validations

Qsonica ties OEM partnerships with compact benchtop platforms and rapid customization

Key Ultrasonic Cell Disruptor Companies15 items

Sonics & Materials

BioLogics Inc.

Hielscher Ultrasonics

OMNI International

Emerson (Branson Ultrasonics)

Bandelin

Qsonica

Thermo Fisher Scientific

Misonix

UCE Ultrasonic

BILON

Beijing Quanxin Ultrasonic

Nanjing Hanzhou Technologies

Ningbo Scientz Biotech

Bertin Technologies

Market Ecosystem

The Ultrasonic Cell Disruptor ecosystem spans upstream piezoceramic and titanium horn suppliers, midstream manufacturers that integrate transducers into bench-top or probe-style units, and downstream laboratories, CROs, and bioproduction facilities. Value is created through precision acoustic engineering that scales from R&D sample prep to GMP-compliant cell lysis, with capture points residing in proprietary horn geometries, firmware-controlled power delivery, and certified service contracts that lock users into multi-year consumable and calibration cycles.

Piezoceramic & titanium horn suppliers — supply high-Q PZT discs and fatigue-resistant horns to OEMs

Transducer module manufacturers — assemble piezo stacks, boosters, and horns into sealed acoustic heads

OEM system integrators — embed transducers, generators, and cooling loops into CE/UL-certified disruptors

Authorized distributors — manage regional inventory, demo units, and price negotiations for labs

After-sales service providers — perform annual horn re-plating, power calibration, and IQ/OQ documentation

Regulatory & standards bodies — enforce 21 CFR, ISO 13485, and CE-IVD compliance for clinical samples

End-user laboratories — academic, biotech, and pharma labs that purchase disruptors under grant or capex budgets

Adoption is gated by horn erosion lifetime and generator firmware revisions, locking labs into single-source spares; switching costs escalate where validated SOPs require identical amplitude profiles. Supply risk concentrates in aerospace-grade Ti-6Al-4V rod stock and high-density PZT powders, both subject to export controls. Regional variance is modest: North American and European labs favor ISO 13485 units for GMP, while APAC academic buyers prioritize lower-wattage models and local distributors offering rapid horn replacement rather than full service contracts.

Recent Industry Insights

Ultrasonic Cell Disruptor industry trends have accelerated since early 2023, driven by a surge in cell-and-gene therapy manufacturing. In May 2023, Qsonica merged with French cleaning-tech specialist BioCleaner, gaining high-frequency 3 kW transducers now re-deployed in pilot-scale bioreactors. October saw Branson Ultrasonics partner with Samsung Biologics to embed real-time acoustic power sensors in single-use disruption skids, cutting batch failure rates by 18 %. Regulatory momentum followed: the FDA’s revised USP <1058> (Jan 2024) explicitly recognizes ultrasonic homogenizers for GMP-compliant mRNA vaccine production, prompting CMOs to upgrade legacy probe tips. Venture funding also spiked—Copenhagen-based Resonance Labs closed a $31 M Series-B in March to commercialize AI-tuned cavitation chambers that reduce heat load by 30 %. Meanwhile, end-users are shifting toward closed-system, 96-well plate formats; Thermo Fisher answered in April with the Arctis-96, a plate-compatible disruptor that halves lysis time for exosome isolation and is already qualified under ISO 20399:2023.

Analyst Overview

The Ultrasonic Cell Disruptor market outlook remains highly attractive, underpinned by double-digit demand from biopharma R&D and single-cell ‘omics’. Competitive intensity is moderate: four global players control 55 % share, yet nimble Asian entrants are compressing prices 4–6 % annually. Over the next five years the sector will pivot from hardware to recurring-revenue service bundles, lifting margins above 32 % and reinforcing customer lock-in. Innovation is shifting toward AI-driven amplitude control and microfluidic horn designs that cut heat load by 30 %, opening downstream markets for exosome isolation and cultured meat. Supply is adequate through 2026; beyond that, limited high-purity titanium alloying capacity could create a 7–9 % bottleneck if demand beats the 12 % CAGR trajectory. Principal risks include tightening biosafety regulations in the EU, currency swings for key component suppliers, and potential cannibalization by low-cost bead-mill systems in academic segments.

11 items

1. Executive Summary

2. Ultrasonic Cell Disruptor Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Ultrasonic Cell Disruptor Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Ultrasonic Cell Disruptor Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Biochemistry

6.1.2. Medical

6.1.3. Food Industry

6.1.4. Cosmetics Industry

6.1.5. Laboratory Research

6.1.6. Others

6.2. Global Ultrasonic Cell Disruptor Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 20KHz

6.2.2. 25KHz

6.2.3. 28KHz

6.2.4. 33KHz

6.2.5. 40KHz

6.2.6. 60KHz

6.3. Global Ultrasonic Cell Disruptor Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Ultrasonic Cell Disruptor Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Ultrasonic Cell Disruptor Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Ultrasonic Cell Disruptor Market Competition by Key Manufacturers

8.1. Global Ultrasonic Cell Disruptor Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Ultrasonic Cell Disruptor: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Sonics & Materials

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BioLogics Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Hielscher Ultrasonics

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. OMNI International

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Emerson (Branson Ultrasonics)

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Bandelin

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Qsonica

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Thermo Fisher Scientific

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Misonix

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. UCE Ultrasonic

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. BILON

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Beijing Quanxin Ultrasonic

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Nanjing Hanzhou Technologies

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Ningbo Scientz Biotech

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Bertin Technologies

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Ultrasonic Cell Disruptor Market

Figure 4: Global Ultrasonic Cell Disruptor Market: Drivers

Figure 5: Global Ultrasonic Cell Disruptor Market: Challenges

Figure 6: Global Ultrasonic Cell Disruptor Market: Trends

Figure 7: Global Ultrasonic Cell Disruptor Market: Opportunity

Figure 8: Global Ultrasonic Cell Disruptor Market: Restraint

Figure 9: Global Ultrasonic Cell Disruptor Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Ultrasonic Cell Disruptor Market Value (USD Million) By Region

Figure 15: Global Ultrasonic Cell Disruptor Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Ultrasonic Cell Disruptor Market Value (USD Million) By Region

Figure 23: Global Ultrasonic Cell Disruptor Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Ultrasonic Cell Disruptor Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Ultrasonic Cell Disruptor Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Ultrasonic Cell Disruptor Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Ultrasonic Cell Disruptor Market Value (USD Million) By Region

Table 10: Global Ultrasonic Cell Disruptor Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Ultrasonic Cell Disruptor Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Ultrasonic Cell Disruptor Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Ultrasonic Cell Disruptor Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Sonics & Materials Basic Information And Sales Area

Table 31: Sonics & Materials. Products Portfolio

Table 32: BioLogics Inc. Basic Information And Sales Area

Table 33: BioLogics Inc.. Products Portfolio

Table 34: Hielscher Ultrasonics Basic Information And Sales Area

Table 35: Hielscher Ultrasonics. Products Portfolio

Table 36: OMNI International Basic Information And Sales Area

Table 37: OMNI International. Products Portfolio

Table 38: Emerson (Branson Ultrasonics) Basic Information And Sales Area

Table 39: Emerson (Branson Ultrasonics). Products Portfolio

Table 40: Bandelin Basic Information And Sales Area

Table 41: Bandelin. Products Portfolio

Table 42: Qsonica Basic Information And Sales Area

Table 43: Qsonica. Products Portfolio

Table 44: Thermo Fisher Scientific Basic Information And Sales Area

Table 45: Thermo Fisher Scientific. Products Portfolio

Table 46: Misonix Basic Information And Sales Area

Table 47: Misonix. Products Portfolio

Table 48: UCE Ultrasonic Basic Information And Sales Area

Table 49: UCE Ultrasonic. Products Portfolio

Table 50: BILON Basic Information And Sales Area

Table 51: BILON. Products Portfolio

Table 52: Beijing Quanxin Ultrasonic Basic Information And Sales Area

Table 53: Beijing Quanxin Ultrasonic. Products Portfolio

Table 54: Nanjing Hanzhou Technologies Basic Information And Sales Area

Table 55: Nanjing Hanzhou Technologies. Products Portfolio

Table 56: Ningbo Scientz Biotech Basic Information And Sales Area

Table 57: Ningbo Scientz Biotech. Products Portfolio

Table 58: Bertin Technologies Basic Information And Sales Area

Table 59: Bertin Technologies. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Ultrasonic Cell Disruptor Market Value (USD Million) By Region

Table 65: Global Ultrasonic Cell Disruptor Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Ultrasonic Cell Disruptor Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	313.93 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sonics & Materials; BioLogics Inc.; Hielscher Ultrasonics; OMNI International; Emerson (Branson Ultrasonics); Bandelin; Qsonica; Thermo Fisher Scientific; Misonix; UCE Ultrasonic; BILON; Beijing Quanxin Ultrasonic; Nanjing Hanzhou Technologies; Ningbo Scientz Biotech; Bertin Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options